Latest Articles
KEYNOTE-A18 Eligibility: Pembro/Chemoradiotherapy in Cervical Cancer - Targeted Oncology
KEYNOTE-A18 Eligibility: Pembro/Chemoradiotherapy in Cervical Cancer Targeted Oncology
Published: Jan. 5, 2024, 8 a.m.
TSLP enhances progestin response in endometrial cancer via androgen receptor signal pathway - Nature.com
TSLP enhances progestin response in endometrial cancer via androgen receptor signal pathway Nature.com
Published: Jan. 3, 2024, 8 a.m.
Young cancer patient opens up on survivor's guilt - BBC.com
Young cancer patient opens up on survivor's guilt BBC.com
Published: Jan. 1, 2024, 8 a.m.
Link copied to clipboard!